1 Market Overview 1.1 Product Overview and Scope of Nervous System Medications 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Nervous System Medications Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 Anesthetic 1.3.3 Painkiller 1.3.4 Psychostimulants 1.3.5 Antiepileptic Drugs 1.3.6 Anti-Parkinson Drugs 1.3.7 Others 1.4 Market Analysis by Application 1.4.1 Overview: Global Nervous System Medications Consumption Value by Application: 2018 Versus 2022 Versus 2029 1.4.2 Hospital Pharmacy 1.4.3 Retail Pharmacy 1.4.4 Online Pharmacy 1.5 Global Nervous System Medications Market Size & Forecast 1.5.1 Global Nervous System Medications Consumption Value (2018 & 2022 & 2029) 1.5.2 Global Nervous System Medications Sales Quantity (2018-2029) 1.5.3 Global Nervous System Medications Average Price (2018-2029) 2 Manufacturers Profiles 2.1 Pfizer 2.1.1 Pfizer Details 2.1.2 Pfizer Major Business 2.1.3 Pfizer Nervous System Medications Product and Services 2.1.4 Pfizer Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.1.5 Pfizer Recent Developments/Updates 2.2 Teva 2.2.1 Teva Details 2.2.2 Teva Major Business 2.2.3 Teva Nervous System Medications Product and Services 2.2.4 Teva Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.2.5 Teva Recent Developments/Updates 2.3 Novartis 2.3.1 Novartis Details 2.3.2 Novartis Major Business 2.3.3 Novartis Nervous System Medications Product and Services 2.3.4 Novartis Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.3.5 Novartis Recent Developments/Updates 2.4 AstraZeneca 2.4.1 AstraZeneca Details 2.4.2 AstraZeneca Major Business 2.4.3 AstraZeneca Nervous System Medications Product and Services 2.4.4 AstraZeneca Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.4.5 AstraZeneca Recent Developments/Updates 2.5 Takeda 2.5.1 Takeda Details 2.5.2 Takeda Major Business 2.5.3 Takeda Nervous System Medications Product and Services 2.5.4 Takeda Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.5.5 Takeda Recent Developments/Updates 2.6 Johnson & Johnson 2.6.1 Johnson & Johnson Details 2.6.2 Johnson & Johnson Major Business 2.6.3 Johnson & Johnson Nervous System Medications Product and Services 2.6.4 Johnson & Johnson Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.6.5 Johnson & Johnson Recent Developments/Updates 2.7 EliLilly 2.7.1 EliLilly Details 2.7.2 EliLilly Major Business 2.7.3 EliLilly Nervous System Medications Product and Services 2.7.4 EliLilly Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.7.5 EliLilly Recent Developments/Updates 2.8 Otsuka 2.8.1 Otsuka Details 2.8.2 Otsuka Major Business 2.8.3 Otsuka Nervous System Medications Product and Services 2.8.4 Otsuka Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.8.5 Otsuka Recent Developments/Updates 2.9 Merck 2.9.1 Merck Details 2.9.2 Merck Major Business 2.9.3 Merck Nervous System Medications Product and Services 2.9.4 Merck Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.9.5 Merck Recent Developments/Updates 2.10 Yangtze River Pharmaceutical 2.10.1 Yangtze River Pharmaceutical Details 2.10.2 Yangtze River Pharmaceutical Major Business 2.10.3 Yangtze River Pharmaceutical Nervous System Medications Product and Services 2.10.4 Yangtze River Pharmaceutical Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.10.5 Yangtze River Pharmaceutical Recent Developments/Updates 2.11 Humanwell Healthcare 2.11.1 Humanwell Healthcare Details 2.11.2 Humanwell Healthcare Major Business 2.11.3 Humanwell Healthcare Nervous System Medications Product and Services 2.11.4 Humanwell Healthcare Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.11.5 Humanwell Healthcare Recent Developments/Updates 2.12 CSPC-NBP Pharmaceutical 2.12.1 CSPC-NBP Pharmaceutical Details 2.12.2 CSPC-NBP Pharmaceutical Major Business 2.12.3 CSPC-NBP Pharmaceutical Nervous System Medications Product and Services 2.12.4 CSPC-NBP Pharmaceutical Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.12.5 CSPC-NBP Pharmaceutical Recent Developments/Updates 2.13 Nhwa Pharmaceutical 2.13.1 Nhwa Pharmaceutical Details 2.13.2 Nhwa Pharmaceutical Major Business 2.13.3 Nhwa Pharmaceutical Nervous System Medications Product and Services 2.13.4 Nhwa Pharmaceutical Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.13.5 Nhwa Pharmaceutical Recent Developments/Updates 2.14 Qilu Pharma 2.14.1 Qilu Pharma Details 2.14.2 Qilu Pharma Major Business 2.14.3 Qilu Pharma Nervous System Medications Product and Services 2.14.4 Qilu Pharma Nervous System Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.14.5 Qilu Pharma Recent Developments/Updates 3 Competitive Environment: Nervous System Medications by Manufacturer 3.1 Global Nervous System Medications Sales Quantity by Manufacturer (2018-2023) 3.2 Global Nervous System Medications Revenue by Manufacturer (2018-2023) 3.3 Global Nervous System Medications Average Price by Manufacturer (2018-2023) 3.4 Market Share Analysis (2022) 3.4.1 Producer Shipments of Nervous System Medications by Manufacturer Revenue ($MM) and Market Share (%): 2022 3.4.2 Top 3 Nervous System Medications Manufacturer Market Share in 2022 3.4.2 Top 6 Nervous System Medications Manufacturer Market Share in 2022 3.5 Nervous System Medications Market: Overall Company Footprint Analysis 3.5.1 Nervous System Medications Market: Region Footprint 3.5.2 Nervous System Medications Market: Company Product Type Footprint 3.5.3 Nervous System Medications Market: Company Product Application Footprint 3.6 New Market Entrants and Barriers to Market Entry 3.7 Mergers, Acquisition, Agreements, and Collaborations 4 Consumption Analysis by Region 4.1 Global Nervous System Medications Market Size by Region 4.1.1 Global Nervous System Medications Sales Quantity by Region (2018-2029) 4.1.2 Global Nervous System Medications Consumption Value by Region (2018-2029) 4.1.3 Global Nervous System Medications Average Price by Region (2018-2029) 4.2 North America Nervous System Medications Consumption Value (2018-2029) 4.3 Europe Nervous System Medications Consumption Value (2018-2029) 4.4 Asia-Pacific Nervous System Medications Consumption Value (2018-2029) 4.5 South America Nervous System Medications Consumption Value (2018-2029) 4.6 Middle East and Africa Nervous System Medications Consumption Value (2018-2029) 5 Market Segment by Type 5.1 Global Nervous System Medications Sales Quantity by Type (2018-2029) 5.2 Global Nervous System Medications Consumption Value by Type (2018-2029) 5.3 Global Nervous System Medications Average Price by Type (2018-2029) 6 Market Segment by Application 6.1 Global Nervous System Medications Sales Quantity by Application (2018-2029) 6.2 Global Nervous System Medications Consumption Value by Application (2018-2029) 6.3 Global Nervous System Medications Average Price by Application (2018-2029) 7 North America 7.1 North America Nervous System Medications Sales Quantity by Type (2018-2029) 7.2 North America Nervous System Medications Sales Quantity by Application (2018-2029) 7.3 North America Nervous System Medications Market Size by Country 7.3.1 North America Nervous System Medications Sales Quantity by Country (2018-2029) 7.3.2 North America Nervous System Medications Consumption Value by Country (2018-2029) 7.3.3 United States Market Size and Forecast (2018-2029) 7.3.4 Canada Market Size and Forecast (2018-2029) 7.3.5 Mexico Market Size and Forecast (2018-2029) 8 Europe 8.1 Europe Nervous System Medications Sales Quantity by Type (2018-2029) 8.2 Europe Nervous System Medications Sales Quantity by Application (2018-2029) 8.3 Europe Nervous System Medications Market Size by Country 8.3.1 Europe Nervous System Medications Sales Quantity by Country (2018-2029) 8.3.2 Europe Nervous System Medications Consumption Value by Country (2018-2029) 8.3.3 Germany Market Size and Forecast (2018-2029) 8.3.4 France Market Size and Forecast (2018-2029) 8.3.5 United Kingdom Market Size and Forecast (2018-2029) 8.3.6 Russia Market Size and Forecast (2018-2029) 8.3.7 Italy Market Size and Forecast (2018-2029) 9 Asia-Pacific 9.1 Asia-Pacific Nervous System Medications Sales Quantity by Type (2018-2029) 9.2 Asia-Pacific Nervous System Medications Sales Quantity by Application (2018-2029) 9.3 Asia-Pacific Nervous System Medications Market Size by Region 9.3.1 Asia-Pacific Nervous System Medications Sales Quantity by Region (2018-2029) 9.3.2 Asia-Pacific Nervous System Medications Consumption Value by Region (2018-2029) 9.3.3 China Market Size and Forecast (2018-2029) 9.3.4 Japan Market Size and Forecast (2018-2029) 9.3.5 Korea Market Size and Forecast (2018-2029) 9.3.6 India Market Size and Forecast (2018-2029) 9.3.7 Southeast Asia Market Size and Forecast (2018-2029) 9.3.8 Australia Market Size and Forecast (2018-2029) 10 South America 10.1 South America Nervous System Medications Sales Quantity by Type (2018-2029) 10.2 South America Nervous System Medications Sales Quantity by Application (2018-2029) 10.3 South America Nervous System Medications Market Size by Country 10.3.1 South America Nervous System Medications Sales Quantity by Country (2018-2029) 10.3.2 South America Nervous System Medications Consumption Value by Country (2018-2029) 10.3.3 Brazil Market Size and Forecast (2018-2029) 10.3.4 Argentina Market Size and Forecast (2018-2029) 11 Middle East & Africa 11.1 Middle East & Africa Nervous System Medications Sales Quantity by Type (2018-2029) 11.2 Middle East & Africa Nervous System Medications Sales Quantity by Application (2018-2029) 11.3 Middle East & Africa Nervous System Medications Market Size by Country 11.3.1 Middle East & Africa Nervous System Medications Sales Quantity by Country (2018-2029) 11.3.2 Middle East & Africa Nervous System Medications Consumption Value by Country (2018-2029) 11.3.3 Turkey Market Size and Forecast (2018-2029) 11.3.4 Egypt Market Size and Forecast (2018-2029) 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029) 11.3.6 South Africa Market Size and Forecast (2018-2029) 12 Market Dynamics 12.1 Nervous System Medications Market Drivers 12.2 Nervous System Medications Market Restraints 12.3 Nervous System Medications Trends Analysis 12.4 Porters Five Forces Analysis 12.4.1 Threat of New Entrants 12.4.2 Bargaining Power of Suppliers 12.4.3 Bargaining Power of Buyers 12.4.4 Threat of Substitutes 12.4.5 Competitive Rivalry 12.5 Influence of COVID-19 and Russia-Ukraine War 12.5.1 Influence of COVID-19 12.5.2 Influence of Russia-Ukraine War 13 Raw Material and Industry Chain 13.1 Raw Material of Nervous System Medications and Key Manufacturers 13.2 Manufacturing Costs Percentage of Nervous System Medications 13.3 Nervous System Medications Production Process 13.4 Nervous System Medications Industrial Chain 14 Shipments by Distribution Channel 14.1 Sales Channel 14.1.1 Direct to End-User 14.1.2 Distributors 14.2 Nervous System Medications Typical Distributors 14.3 Nervous System Medications Typical Customers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology 16.2 Research Process and Data Source 16.3 Disclaimer

List of Tables Table 1. Global Nervous System Medications Consumption Value by Type, (USD Million), 2018 & 2022 & 2029 Table 2. Global Nervous System Medications Consumption Value by Application, (USD Million), 2018 & 2022 & 2029 Table 3. Pfizer Basic Information, Manufacturing Base and Competitors Table 4. Pfizer Major Business Table 5. Pfizer Nervous System Medications Product and Services Table 6. Pfizer Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 7. Pfizer Recent Developments/Updates Table 8. Teva Basic Information, Manufacturing Base and Competitors Table 9. Teva Major Business Table 10. Teva Nervous System Medications Product and Services Table 11. Teva Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 12. Teva Recent Developments/Updates Table 13. Novartis Basic Information, Manufacturing Base and Competitors Table 14. Novartis Major Business Table 15. Novartis Nervous System Medications Product and Services Table 16. Novartis Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 17. Novartis Recent Developments/Updates Table 18. AstraZeneca Basic Information, Manufacturing Base and Competitors Table 19. AstraZeneca Major Business Table 20. AstraZeneca Nervous System Medications Product and Services Table 21. AstraZeneca Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 22. AstraZeneca Recent Developments/Updates Table 23. Takeda Basic Information, Manufacturing Base and Competitors Table 24. Takeda Major Business Table 25. Takeda Nervous System Medications Product and Services Table 26. Takeda Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 27. Takeda Recent Developments/Updates Table 28. Johnson & Johnson Basic Information, Manufacturing Base and Competitors Table 29. Johnson & Johnson Major Business Table 30. Johnson & Johnson Nervous System Medications Product and Services Table 31. Johnson & Johnson Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 32. Johnson & Johnson Recent Developments/Updates Table 33. EliLilly Basic Information, Manufacturing Base and Competitors Table 34. EliLilly Major Business Table 35. EliLilly Nervous System Medications Product and Services Table 36. EliLilly Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 37. EliLilly Recent Developments/Updates Table 38. Otsuka Basic Information, Manufacturing Base and Competitors Table 39. Otsuka Major Business Table 40. Otsuka Nervous System Medications Product and Services Table 41. Otsuka Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 42. Otsuka Recent Developments/Updates Table 43. Merck Basic Information, Manufacturing Base and Competitors Table 44. Merck Major Business Table 45. Merck Nervous System Medications Product and Services Table 46. Merck Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 47. Merck Recent Developments/Updates Table 48. Yangtze River Pharmaceutical Basic Information, Manufacturing Base and Competitors Table 49. Yangtze River Pharmaceutical Major Business Table 50. Yangtze River Pharmaceutical Nervous System Medications Product and Services Table 51. Yangtze River Pharmaceutical Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 52. Yangtze River Pharmaceutical Recent Developments/Updates Table 53. Humanwell Healthcare Basic Information, Manufacturing Base and Competitors Table 54. Humanwell Healthcare Major Business Table 55. Humanwell Healthcare Nervous System Medications Product and Services Table 56. Humanwell Healthcare Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 57. Humanwell Healthcare Recent Developments/Updates Table 58. CSPC-NBP Pharmaceutical Basic Information, Manufacturing Base and Competitors Table 59. CSPC-NBP Pharmaceutical Major Business Table 60. CSPC-NBP Pharmaceutical Nervous System Medications Product and Services Table 61. CSPC-NBP Pharmaceutical Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 62. CSPC-NBP Pharmaceutical Recent Developments/Updates Table 63. Nhwa Pharmaceutical Basic Information, Manufacturing Base and Competitors Table 64. Nhwa Pharmaceutical Major Business Table 65. Nhwa Pharmaceutical Nervous System Medications Product and Services Table 66. Nhwa Pharmaceutical Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 67. Nhwa Pharmaceutical Recent Developments/Updates Table 68. Qilu Pharma Basic Information, Manufacturing Base and Competitors Table 69. Qilu Pharma Major Business Table 70. Qilu Pharma Nervous System Medications Product and Services Table 71. Qilu Pharma Nervous System Medications Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 72. Qilu Pharma Recent Developments/Updates Table 73. Global Nervous System Medications Sales Quantity by Manufacturer (2018-2023) & (K Units) Table 74. Global Nervous System Medications Revenue by Manufacturer (2018-2023) & (USD Million) Table 75. Global Nervous System Medications Average Price by Manufacturer (2018-2023) & (US$/Unit) Table 76. Market Position of Manufacturers in Nervous System Medications, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022 Table 77. Head Office and Nervous System Medications Production Site of Key Manufacturer Table 78. Nervous System Medications Market: Company Product Type Footprint Table 79. Nervous System Medications Market: Company Product Application Footprint Table 80. Nervous System Medications New Market Entrants and Barriers to Market Entry Table 81. Nervous System Medications Mergers, Acquisition, Agreements, and Collaborations Table 82. Global Nervous System Medications Sales Quantity by Region (2018-2023) & (K Units) Table 83. Global Nervous System Medications Sales Quantity by Region (2024-2029) & (K Units) Table 84. Global Nervous System Medications Consumption Value by Region (2018-2023) & (USD Million) Table 85. Global Nervous System Medications Consumption Value by Region (2024-2029) & (USD Million) Table 86. Global Nervous System Medications Average Price by Region (2018-2023) & (US$/Unit) Table 87. Global Nervous System Medications Average Price by Region (2024-2029) & (US$/Unit) Table 88. Global Nervous System Medications Sales Quantity by Type (2018-2023) & (K Units) Table 89. Global Nervous System Medications Sales Quantity by Type (2024-2029) & (K Units) Table 90. Global Nervous System Medications Consumption Value by Type (2018-2023) & (USD Million) Table 91. Global Nervous System Medications Consumption Value by Type (2024-2029) & (USD Million) Table 92. Global Nervous System Medications Average Price by Type (2018-2023) & (US$/Unit) Table 93. Global Nervous System Medications Average Price by Type (2024-2029) & (US$/Unit) Table 94. Global Nervous System Medications Sales Quantity by Application (2018-2023) & (K Units) Table 95. Global Nervous System Medications Sales Quantity by Application (2024-2029) & (K Units) Table 96. Global Nervous System Medications Consumption Value by Application (2018-2023) & (USD Million) Table 97. Global Nervous System Medications Consumption Value by Application (2024-2029) & (USD Million) Table 98. Global Nervous System Medications Average Price by Application (2018-2023) & (US$/Unit) Table 99. Global Nervous System Medications Average Price by Application (2024-2029) & (US$/Unit) Table 100. North America Nervous System Medications Sales Quantity by Type (2018-2023) & (K Units) Table 101. North America Nervous System Medications Sales Quantity by Type (2024-2029) & (K Units) Table 102. North America Nervous System Medications Sales Quantity by Application (2018-2023) & (K Units) Table 103. North America Nervous System Medications Sales Quantity by Application (2024-2029) & (K Units) Table 104. North America Nervous System Medications Sales Quantity by Country (2018-2023) & (K Units) Table 105. North America Nervous System Medications Sales Quantity by Country (2024-2029) & (K Units) Table 106. North America Nervous System Medications Consumption Value by Country (2018-2023) & (USD Million) Table 107. North America Nervous System Medications Consumption Value by Country (2024-2029) & (USD Million) Table 108. Europe Nervous System Medications Sales Quantity by Type (2018-2023) & (K Units) Table 109. Europe Nervous System Medications Sales Quantity by Type (2024-2029) & (K Units) Table 110. Europe Nervous System Medications Sales Quantity by Application (2018-2023) & (K Units) Table 111. Europe Nervous System Medications Sales Quantity by Application (2024-2029) & (K Units) Table 112. Europe Nervous System Medications Sales Quantity by Country (2018-2023) & (K Units) Table 113. Europe Nervous System Medications Sales Quantity by Country (2024-2029) & (K Units) Table 114. Europe Nervous System Medications Consumption Value by Country (2018-2023) & (USD Million) Table 115. Europe Nervous System Medications Consumption Value by Country (2024-2029) & (USD Million) Table 116. Asia-Pacific Nervous System Medications Sales Quantity by Type (2018-2023) & (K Units) Table 117. Asia-Pacific Nervous System Medications Sales Quantity by Type (2024-2029) & (K Units) Table 118. Asia-Pacific Nervous System Medications Sales Quantity by Application (2018-2023) & (K Units) Table 119. Asia-Pacific Nervous System Medications Sales Quantity by Application (2024-2029) & (K Units) Table 120. Asia-Pacific Nervous System Medications Sales Quantity by Region (2018-2023) & (K Units) Table 121. Asia-Pacific Nervous System Medications Sales Quantity by Region (2024-2029) & (K Units) Table 122. Asia-Pacific Nervous System Medications Consumption Value by Region (2018-2023) & (USD Million) Table 123. Asia-Pacific Nervous System Medications Consumption Value by Region (2024-2029) & (USD Million) Table 124. South America Nervous System Medications Sales Quantity by Type (2018-2023) & (K Units) Table 125. South America Nervous System Medications Sales Quantity by Type (2024-2029) & (K Units) Table 126. South America Nervous System Medications Sales Quantity by Application (2018-2023) & (K Units) Table 127. South America Nervous System Medications Sales Quantity by Application (2024-2029) & (K Units) Table 128. South America Nervous System Medications Sales Quantity by Country (2018-2023) & (K Units) Table 129. South America Nervous System Medications Sales Quantity by Country (2024-2029) & (K Units) Table 130. South America Nervous System Medications Consumption Value by Country (2018-2023) & (USD Million) Table 131. South America Nervous System Medications Consumption Value by Country (2024-2029) & (USD Million) Table 132. Middle East & Africa Nervous System Medications Sales Quantity by Type (2018-2023) & (K Units) Table 133. Middle East & Africa Nervous System Medications Sales Quantity by Type (2024-2029) & (K Units) Table 134. Middle East & Africa Nervous System Medications Sales Quantity by Application (2018-2023) & (K Units) Table 135. Middle East & Africa Nervous System Medications Sales Quantity by Application (2024-2029) & (K Units) Table 136. Middle East & Africa Nervous System Medications Sales Quantity by Region (2018-2023) & (K Units) Table 137. Middle East & Africa Nervous System Medications Sales Quantity by Region (2024-2029) & (K Units) Table 138. Middle East & Africa Nervous System Medications Consumption Value by Region (2018-2023) & (USD Million) Table 139. Middle East & Africa Nervous System Medications Consumption Value by Region (2024-2029) & (USD Million) Table 140. Nervous System Medications Raw Material Table 141. Key Manufacturers of Nervous System Medications Raw Materials Table 142. Nervous System Medications Typical Distributors Table 143. Nervous System Medications Typical Customers List of Figures Figure 1. Nervous System Medications Picture Figure 2. Global Nervous System Medications Consumption Value by Type, (USD Million), 2018 & 2022 & 2029 Figure 3. Global Nervous System Medications Consumption Value Market Share by Type in 2022 Figure 4. Anesthetic Examples Figure 5. Painkiller Examples Figure 6. Psychostimulants Examples Figure 7. Antiepileptic Drugs Examples Figure 8. Anti-Parkinson Drugs Examples Figure 9. Others Examples Figure 10. Global Nervous System Medications Consumption Value by Application, (USD Million), 2018 & 2022 & 2029 Figure 11. Global Nervous System Medications Consumption Value Market Share by Application in 2022 Figure 12. Hospital Pharmacy Examples Figure 13. Retail Pharmacy Examples Figure 14. Online Pharmacy Examples Figure 15. Global Nervous System Medications Consumption Value, (USD Million): 2018 & 2022 & 2029 Figure 16. Global Nervous System Medications Consumption Value and Forecast (2018-2029) & (USD Million) Figure 17. Global Nervous System Medications Sales Quantity (2018-2029) & (K Units) Figure 18. Global Nervous System Medications Average Price (2018-2029) & (US$/Unit) Figure 19. Global Nervous System Medications Sales Quantity Market Share by Manufacturer in 2022 Figure 20. Global Nervous System Medications Consumption Value Market Share by Manufacturer in 2022 Figure 21. Producer Shipments of Nervous System Medications by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021 Figure 22. Top 3 Nervous System Medications Manufacturer (Consumption Value) Market Share in 2022 Figure 23. Top 6 Nervous System Medications Manufacturer (Consumption Value) Market Share in 2022 Figure 24. Global Nervous System Medications Sales Quantity Market Share by Region (2018-2029) Figure 25. Global Nervous System Medications Consumption Value Market Share by Region (2018-2029) Figure 26. North America Nervous System Medications Consumption Value (2018-2029) & (USD Million) Figure 27. Europe Nervous System Medications Consumption Value (2018-2029) & (USD Million) Figure 28. Asia-Pacific Nervous System Medications Consumption Value (2018-2029) & (USD Million) Figure 29. South America Nervous System Medications Consumption Value (2018-2029) & (USD Million) Figure 30. Middle East & Africa Nervous System Medications Consumption Value (2018-2029) & (USD Million) Figure 31. Global Nervous System Medications Sales Quantity Market Share by Type (2018-2029) Figure 32. Global Nervous System Medications Consumption Value Market Share by Type (2018-2029) Figure 33. Global Nervous System Medications Average Price by Type (2018-2029) & (US$/Unit) Figure 34. Global Nervous System Medications Sales Quantity Market Share by Application (2018-2029) Figure 35. Global Nervous System Medications Consumption Value Market Share by Application (2018-2029) Figure 36. Global Nervous System Medications Average Price by Application (2018-2029) & (US$/Unit) Figure 37. North America Nervous System Medications Sales Quantity Market Share by Type (2018-2029) Figure 38. North America Nervous System Medications Sales Quantity Market Share by Application (2018-2029) Figure 39. North America Nervous System Medications Sales Quantity Market Share by Country (2018-2029) Figure 40. North America Nervous System Medications Consumption Value Market Share by Country (2018-2029) Figure 41. United States Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 42. Canada Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 43. Mexico Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 44. Europe Nervous System Medications Sales Quantity Market Share by Type (2018-2029) Figure 45. Europe Nervous System Medications Sales Quantity Market Share by Application (2018-2029) Figure 46. Europe Nervous System Medications Sales Quantity Market Share by Country (2018-2029) Figure 47. Europe Nervous System Medications Consumption Value Market Share by Country (2018-2029) Figure 48. Germany Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 49. France Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 50. United Kingdom Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 51. Russia Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 52. Italy Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 53. Asia-Pacific Nervous System Medications Sales Quantity Market Share by Type (2018-2029) Figure 54. Asia-Pacific Nervous System Medications Sales Quantity Market Share by Application (2018-2029) Figure 55. Asia-Pacific Nervous System Medications Sales Quantity Market Share by Region (2018-2029) Figure 56. Asia-Pacific Nervous System Medications Consumption Value Market Share by Region (2018-2029) Figure 57. China Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 58. Japan Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 59. Korea Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 60. India Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 61. Southeast Asia Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 62. Australia Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 63. South America Nervous System Medications Sales Quantity Market Share by Type (2018-2029) Figure 64. South America Nervous System Medications Sales Quantity Market Share by Application (2018-2029) Figure 65. South America Nervous System Medications Sales Quantity Market Share by Country (2018-2029) Figure 66. South America Nervous System Medications Consumption Value Market Share by Country (2018-2029) Figure 67. Brazil Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 68. Argentina Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 69. Middle East & Africa Nervous System Medications Sales Quantity Market Share by Type (2018-2029) Figure 70. Middle East & Africa Nervous System Medications Sales Quantity Market Share by Application (2018-2029) Figure 71. Middle East & Africa Nervous System Medications Sales Quantity Market Share by Region (2018-2029) Figure 72. Middle East & Africa Nervous System Medications Consumption Value Market Share by Region (2018-2029) Figure 73. Turkey Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 74. Egypt Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 75. Saudi Arabia Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 76. South Africa Nervous System Medications Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 77. Nervous System Medications Market Drivers Figure 78. Nervous System Medications Market Restraints Figure 79. Nervous System Medications Market Trends Figure 80. Porters Five Forces Analysis Figure 81. Manufacturing Cost Structure Analysis of Nervous System Medications in 2022 Figure 82. Manufacturing Process Analysis of Nervous System Medications Figure 83. Nervous System Medications Industrial Chain Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors Figure 85. Direct Channel Pros & Cons Figure 86. Indirect Channel Pros & Cons Figure 87. Methodology Figure 88. Research Process and Data Source

Pfizer Teva Novartis AstraZeneca Takeda Johnson & Johnson EliLilly Otsuka Merck Yangtze River Pharmaceutical Humanwell Healthcare CSPC-NBP Pharmaceutical Nhwa Pharmaceutical Qilu Pharma